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Abstract
Giardiasis is a communicable gastrointestinal disease caused by Giardia duodenalis and two genetic assemblages, A and B,
cause human infection. In remote Indigenous communities of Australia, giardiasis is highly prevalent among children but
disease transmission is poorly understood. This study investigated the prevalence of Giardia and genetic subtypes
contributing to human disease in a remote Indigenous community, in the Northern Territory of Australia. Eighty-seven
faecal samples were collected from 74 children (,15 years) over an 18 month period, and the distribution of positive cases
relative to participant age and gender were examined. Screening by microscopy and 18S rRNA PCR amplification showed
66.7% (58/87) of faecal samples were positive for Giardia. Both males and females were equally affected and high detection
rates were obtained for participants aged 0–,5 years and 5–,10 years (66.0 and 60.0% respectively). For 58.6% of the
positive samples, Giardia was only detected by 18S rRNA PCR. Approximately 75% of cases were assemblage B, and
subassemblage analyses using terminal restriction fragment length polymorphism of the glutamate dehydrogenase gene
demonstrated that a variety of genetic variants were present. The high proportion of positive cases that were not detectable
by microscopy, and dominance of assemblage B cases highlights the need for further research in this community, to assess
the contribution of Giardia to chronic gastrointestinal disease among children, and to understand conditions conductive to
assemblage B transmission.
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Introduction
In Australia, the mortality rates for Indigenous children (0–14
years) are more than two times higher than the rates for non-
Indigenous children, and overall life expectancy of Indigenous
Australians remains 9.7–11.5 years below the non-Indigenous
population [1]. In remote Indigenous communities, high rates of
gastrointestinal, respiratory, and skin infections are common and
children are most at risk from constant infection and re-infection
[2]. Chronic childhood infections are linked to poor physical and
cognitive development, poor educational outcomes, socio-eco-
nomic disadvantage, and poor health status throughout life [3].
Giardia duodenalis, a protozoan parasite, is a significant cause
of gastrointestinal disease (giardiasis) and morbidity [4]. In remote
Indigenous communities giardiasis prevalence is high, ranging
from 15 to 36% [4,5], compared to a national prevalence of 2 to
7% [6]. Among Indigenous children living in remote communities,
prevalence of giardiasis is estimated between 32 to 65% and
frequency of transmission is comparable to rates observed in
developing nations [4,7,8]. Constant exposure to Giardia leads to
chronic gastrointestinal disease, malnutrition, and failure to thrive
[9].
In the Northern Territory of Australia approximately 80% of
the Indigenous population live in areas classified as remote or very
remote [1,10]. Communities range in size from small groups to a
few thousand people, and communities are geographically isolated
[10]. Overcrowded living conditions, inadequate housing and
community sanitation facilities, and poor personal hygiene
contribute to the high rates of disease transmission in these
communities [10]. Previous initiatives to manage infectious
diseases have included improved housing and community wide
drug treatment programs; however, many diseases continue to
persist with high infection rates [2,3]. The high frequency of
Giardia transmission and continued persistence in remote
Indigenous communities is poorly understood.
Giardia duodenalis is a species complex and two genetic
assemblages (A and B) infect humans, domestic animals, and
wildlife [11,12]. These assemblages are broad clusters of geneti-
cally related isolates [6] and four human infective subassemblages
(AI, AII, BIII and BIV) have been previously described [13,14].
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Genetic diversity within assemblage B, however, is higher than
assemblage A; assemblage B subgroups are unresolved; and
numerous assemblage B genotypes contribute to human and
animal infection [13,15]. Identification of different genetic types
that contribute to disease enables differences in host specificities,
transmission cycles, and sources of infection to be more closely
examined [15].
Several epidemiological studies of giardiasis have been con-
ducted in remote Indigenous communities in Australia [4,7,8], but
few have performed molecular analyses [16,17] to identify genetic
subtypes contributing to high infection rates. The few molecular
epidemiological studies that have been undertaken predate the
current understanding of Giardia, generated by molecular
methods [16,17]. Subtype identification requires analyses of G.
duodenalis DNA and are not conducted in routine pathology
screenings. The geographic remoteness of communities limits
access and feasibility of performing offsite DNA screening for
samples. Additionally, in the Northern Territory giardiasis is not
listed as a notifiable disease and epidemiological information is not
routinely collected for positive cases. It is unclear if different G.
duodenalis genetic variants exist in communities and contribute to
high reinfections rates among children [8].
The purpose of this study was to investigate the prevalence of G.
duodenalis among children in a remote Indigenous Australian
community, and to examine the distribution of genetic assem-
blages and diversity of subtypes present. Knowledge of G.
duodenalis assemblages and subtypes is required to understand
disease transmission, assess public health risks posed by commu-
nity conditions, and to understand how these factors contribute to
persistent giardiasis infections in these communities.
Materials and Methods
Ethics statement
Ethical approval for the community based mass drug admin-
istration trial, including the collection and analysis of faecal
samples, was obtained from the Human Research Ethics
Committee of the Menzies School of Health Research and
Northern Territory Department of Health. Additional approval
for the analysis of the faecal samples was also obtained from the
Macquarie University Human Research Ethics Committee.
Written informed consent was obtained from the parent or
guardian for the collection and analysis of faecal samples from
children. Participant age group and gender were used to analyse
the distribution of Giardia positive cases. No additional or
identifying information was provided for participants included in
this study.
Faecal samples, microscopy and DNA extraction
To investigate the prevalence of G. duodenalis, we examined 87
faecal samples that were collected as part of a mass drug
administration trial of ivermectin for the control of scabies and
strongyloidiasis in a remote community in the Northern Territory
[18]. Faecal samples were acquired from children aged less than
15 years as a routine component of the primary study [18]. A total
of 87 faecal samples were collected from 74 children at three times
points over an 18 month period. Samples were examined by direct
smear for the presence of Giardia and the remainder stored in
ethanol at 220uC until DNA extraction. DNA was extracted from
200 mg of faeces using a PowerSoil DNA Isolation Kit (Mo Bio,
Calsbad, CA) according to the manufacturer’s instructions.
PCR and sequence analyses of the 18S rRNA gene
DNA samples were screened for the presence of Giardia DNA
by PCR amplification of a fragment of the small subunit ribosomal
RNA (18S rRNA) gene, using a two-step nested PCR method and
cycling conditions described [17,19] with primers RH11,
RH4LM, GiAR18SeR and GiAR18SiR. The GC-RICH PCR
System, dNTPack (Roche Diagnostics, Indianapolis, IN, USA) was
used to prepare PCR reactions as previously described [20,21], in
a total volume of 25 ml, containing 1 ml of template DNA.
DNA sequencing was performed for 18S rRNA PCR products
to identify Giardia duodenalis assemblages. Positive secondary
PCR products were purified with a QIAquick PCR Purification
Kit (Qiagen, Melbourne, Australia), according to the manufac-
turer’s instructions. Purified PCR products were sequenced by
Macrogen Inc. (Seoul, Korea) in both the forward and reverse
directions using the secondary PCR primers (GiaR18SeR and
GiaR18SiR). Geneious PRO version 5.3.6 (Biomatters Ltd,
Auckland, New Zealand) was used to generate a contiguous 18S
rRNA sequence (174–175 bp) for each sample. To identify G.
duodenalis assemblages from 18S rRNA contigs, BLASTn
sequence searches of the NCBI GenBank database (http://www.
ncbi.nlm.gov/genbank/index.html) were performed. 18S rRNA
contigs were aligned to previously described 18S rRNA sequences
retrieved from the GenBank database (accession numbers
AF199446 (assemblage A), AF199447 (assemblage B), AF199449
(assemblage C), AF199443 (assemblage D), AF199448 (assemblage
E), AF199444 (assemblage F), AF199450 (assemblage G) [22].
Nucleotide sequence alignments were performed using Clustal W
[23] in Geneious PRO. All 18S rRNA contiguous sequences that
were generated in this study were submitted to the European
Nucleotide Archive (ENA) (http://www.ebi.ac.uk/ena) under
accession numbers LN611577–LN611621.
Terminal-restriction fragment length polymorphism
(T-RFLP) for gdh products
PCR amplification of the glutamate dehydrogenase (gdh) gene
was performed for all samples to enable subassemblage identifi-
cation. A 432bp fragment of the gdh gene was amplified following
the semi-nested protocol and cycling conditions described [14]
using primers GDHeF, GDHiF and GDHiR. The GC-RICH
PCR System, dNTPack was used to prepare the reactions [21] in a
total volume of 25 ml, containing 1 ml of template DNA.
To identify G. duodenalis subassemblages and examine the
population structure of individual infections, gdh PCR products
were analysed by T-RFLP using the method previously described
[24]. Secondary fluorescent PCR was conducted on gdh PCR
positive samples and products were purified as described above.
To generate fluorescent terminal restriction fragments (T-RFs),
products were digested with two restriction endonucleases; Nla IV
(New England BioLabs) and Rsa I (Roche Diagnostics, Indianap-
olis, IN, USA) [14]. Fluorescent T-RFs were detected by capillary
electrophoresis at the Macquarie University Sequencing Facility
[25]. Length in basepairs of T-RFs were estimated using the DNA
size standard LIZ 500 (Applied Biosystems) and GeneScan
software version 4.0 (Applied Biosystems) [24,25].
Statistical analyses
Differences in Giardia positivity and G. duodenalis assemblages
among males and females, participant age groups, and collection
round were investigated using chi-squared statistical analyses. The
frequency of males and females among the total number of
samples collected were used to determine expected frequencies for
Giardia positivity, assuming no gender bias for Giardia infections,
Giardia Subtypes in a Remote Indigenous Community
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and assuming equal distributions of genetic assemblages. The
number of samples collected for participants aged .10 years, and
those collected in round 3 were too small to determine the
statistical significance of results, and were recorded as observa-
tions.
Results
Comparison of Giardia screening results over the 18
month collection period
Screening for Giardia by microscopy and 18S rRNA PCR
produced positive results for a total of 58/87 (66.7%) faecal
samples collected over the study period (Table 1). A total of 24/87
(27.6%) were positive by microscopy, and 54/87 (62.1%) were
positive by 18S rRNA PCR amplification (Table 1). Comparison
of results showed that of the 58 positive samples, 20/58 (34.5%)
were positive by both screening methods, 34/58 (58.6%) were
positive by 18S rRNA PCR only, and 4/58 (6.9%) samples were
positive by microscopy only. Giardia was not detected by either
screening method in 29/87 (33.3%) samples.
Detection rates of Giardia in faecal samples (combined
microscopy and PCR results) were high in all three collection
periods. At round 1 (month 0), 54.3% (19/35) of samples were
positive, 72.3% (34/47) were positive at round 2 (month 12), and
all five of the samples collected during a more limited follow-up at
round 3 (month 18) were positive (Table 1). The increase in
positivity detected between rounds 1 and 2 was almost entirely
attributable to an increase in PCR positivity in round 2, compared
with round 1. There was no difference in the percentage of positive
samples detected by microscopy at the two collection rounds (11/
35 (31.4%) versus 11/47 (23.4%) respectively) (Table 1).
Giardia positivity for 74 participants by age, gender and
collection round
In total there were 74 participants that contributed the 87 faecal
samples over the 18 month collection period. Of the 13
participants that contributed samples twice, 11 contributed
samples at rounds 1 and 2 of collection, and two participants
contributed samples at rounds 2 and 3 of collection. Only the first
sample was included for each participant in the following analyses
based on total participants. Participants were aged 0–,5 years
(50/74, 67.6%), 5–,10 years (20/74, 27.0%), and 10–,15 years
(4/74, 5.4%). There were slightly more males (38/74, (51.4%)
than females (36/74, 48.6%) included in the study (Table 1).
The total number of participants with positive screening results
for Giardia by microscopy and/or 18S PCR was 48/74 (64.9%)
(Table 1). There was no difference in the total number of positive
males (25/48, 52.1%) and females (23/48, 47.9%), or between
those aged 0–,5 years (33/50, 66.0%) and 5–,10 years (12/20,
60.0%). A total of 19/74 (25.7%) participants were positive for
Giardia by microscopy. There was no difference in microscopy
positivity between the two age groups (0–,5 years 13/50, 26.0%;
5–,10 years 6/20, 30.0%); however, more males were positive
(13/19, 68.4%) than females (6/19, 25.7%).
A total of 45/74 participants were 18S rRNA PCR positive and
there was no difference in the proportion of positive males (24/45,
53.3%) and females (21/45, 46.7%) (Table 1). PCR positivity,
however, was 46.7% greater for those aged 0–,5 years (33/50,
66.0% positive) compared with those aged 5–,10 years (9/20,
45.0% positive) (Chi-sq = 7.26, df = 1, p-value = 0.01). For partic-
ipants aged 0–,5 years, 18S rRNA positivity was higher at
collection round 2 (23/30, 76.7%) compared with collection round
1 (14/27,51.9%) (Chi-square = 5.66, df = 1, p-value = 0.02), and
this was consistent with the increase in 18S rRNA PCR positivity
previously described for round 2. Changes in PCR positivity for
participants aged 5–,10 years and 10–,15 years between
collection rounds 1 and 2 could not be determined due to small
sample numbers within these groups. The equal distributions of
18S rRNA positivity among males and females, however, were
maintained between rounds 1 and 2 (Table 1).
DNA sequence analyses of 18S rRNA amplicons and
identification of Giardia assemblages A and B
DNA sequencing was successful for 45/54 18S rRNA PCR
positive samples, and a complete contiguous sequence for the
secondary PCR product was assembled for 43 samples. A shorter
(158 bp) contiguous 18S rRNA sequence was assembled for two
further samples. Polymorphic nucleotide positions for all Giardia
assemblages were within this 158 bp region, and thus it was
possible to genotype the shorter contiguous sequences.
BLASTn sequence searches and nucleotide alignment to
reference sequences obtained from GenBank (previously de-
scribed) identified only assemblages A and B among the samples.
A total of 41/45 sequences were 100% identical to the published
sequences for either assemblage A or assemblage B. The
remaining four sequences contained a novel single nucleotide
deletion at position 162 of the 175 bp 18S rRNA contig, but were
otherwise identical to either assemblage A or assemblage B.
Both assemblage A and assemblage B were detected in faecal
samples from all three collection periods (Table 2). For the 45
samples genotyped, the majority were identified as assemblage B
(34/45, 75.6%), while assemblage A was identified in less than a
quarter of samples (11/45, 24.4%) (Table 2). Assemblage B was
more commonly found at each of the three collection time periods,
in each of the three age groups, and in both males and females
(Table 2). Despite an increase in Giardia 18S rRNA positivity at
collection round 2 (previously described), there was no significant
difference in the frequencies of assemblages A and B at collection
round 2, compared with round 1 (Table 2).
Identification of Giardia subassemblages by gdh T-RFLP
and distribution among samples
A total of 33/87 faecal samples were amplified at the gdh locus
and genotyping by T-RFLP was successful for 32 samples. Gdh T-
RFLP analyses identified four different types of genetic profiles
present in the samples. Within assemblage A, subassemblage AII
was detected in 8/32 (25%) samples (Table 3). Subassemblage AI
was not identified. Within assemblage B, two genotypes were
detected and both were consistent with the previously described
BIII and BIV subassemblages at the gdh locus [14]. For
consistency, the assemblage B genotypes detected in this study
have been labelled as BIII or BIV. Both genotypes were detected
separately in samples: BIII (3/32 samples, 9.4%); BIV (12/32
samples, 37.5%) and; as mixed samples of BIII and BIV (9/32
samples, 28.1%) (Table 3). All four infection profiles (AII, BIII,
BIV, mixed BIII/BIV) were observed at rounds 1 and 2 of
collection (Table 3).
Of the 32 samples genotyped at the gdh locus, 28 were also
positive by 18S rRNA PCR and of these, 24 were successfully
genotyped by 18S rRNA DNA sequencing. Four samples were
positive at the gdh locus only, but could not be confirmed by 18S
rRNA PCR or microscopic examination. Comparison of the gdh
and 18S rRNA genotyping results showed that assignment of
assemblage A and B by gdh-T-RFLP and 18S rRNA DNA
sequencing was concordant.
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Giardia positivity and identification of Giardia
assemblages among participants that contributed
samples at two collection rounds
Thirteen participants contributed samples at two collection
rounds (previously described). Of these, 8/9 participants who were
18S rRNA positive at the second collection round were also
positive at the first round, and may represent ongoing infections.
Of these, 4 participants positive at collection rounds 1 and 2, and
one participant positive at collection rounds 2 and 3 were
successfully genotyped by 18S rRNA sequencing. All 5 partici-
pants were genotyped as assemblage B at both collection rounds
where samples were contributed. The gdh T-RFLP data showed
that 3 of these participants had the same assemblage B subtypes
(BIV, mixed BIII/BIV) at both rounds 1 and 2. To determine if
the presence of ongoing infections contributed to the significant
increase in 18S rRNA positivity at collection round 2, these
participants were removed from the round 2 data and the above
analyses were repeated. The results showed that the increase in
Giardia 18S rRNA positive samples in round 2 of collection
remained statistically supported (data not shown).
Discussion
In this study we investigated the prevalence of Giardia, and
genetic subtypes present in children living in a remote Indigenous
community in the Northern Territory. Screening by direct
microscopy and 18S rRNA PCR amplification showed that
Giardia was highly prevalent (66.7%) in faecal samples collected
over an 18 month period. The high prevalence of Giardia detected
in this study is similar to high rates (65%) of Giardia previously
reported for children living in remote Indigenous communities in
Australia [8]. The highest prevalence of Giardia was found in 0–
,5 year olds, which is similar to that found in low prevalence
regions of Australia, where infants aged 0–4 years are the most
commonly affected group by sporadic giardiasis [26,27].
PCR for the 18S rRNA gene proved to be the most sensitive
method to detect Giardia in the faecal samples. Of the 58 positive
samples, 41.4% of these were detected as positive by microscopy,
whilst 93.1% were detected as positive using the 18S rRNA PCR.
The sensitivity of PCR detection also differed between the two
Giardia loci that were examined. Differences in detection rates for
microscopy and PCR screenings are expected due to intermittent
and/or low parasite shedding, DNA polymerase inhibitors in
faecal material, and differences in gene copy number for the gdh
and 18S rRNA loci [11,28,29]. Previous studies in remote
Indigenous communities of Australia have used microscopy as a
preliminary screening tool to determine Giardia positivity, and
select samples for downstream molecular analyses [17]. The results
of the present study, however, demonstrate that a large proportion
(58.6%) of positive cases were only detectable by 18S rRNA PCR.
Although detection of Giardia DNA by PCR is not direct evidence
of an established infection, PCR is highly sensitive [30,31]. Similar
screening results have been reported from children living in high
prevalence regions of Rwanda, and may reflect low parasite
shedding due to constant exposure and chronic infections [28].
Giardia was detected in faecal samples from all three collection
periods over the 18 month study and high detection rates were
maintained over time. A significant increase in PCR positivity,
from 45.7% to 70.2%, was detected between collection rounds 1
and 2, and was consistent with an increase in positivity among the
0–,5 year age group over this time. No differences in the
frequency of positive cases among males and females, and among
assemblage A and B between collection rounds 1 and 2 were
detected. Our results suggest an overall increase in PCR positivity
during the study; however, further sampling in this community
would be required to resolve this. Sample sizes for older age
groups were small and participants included in this study were self
selected. Participants may have been more likely to provide a
faecal sample if gastrointestinal symptoms were present, but
additional information pertaining to participant symptoms was not
available for this study. It is unknown if PCR positive cases
represent established infections, or if the increase in positivity at
round 2 represents an increase in Giardia infections in this
community. In low prevalence regions of Australia, Giardia
infections fluctuate across demographic groups and with seasonal
changes [27]. Factors influencing prevalence in remote Indigenous
communities in the Northern Territory are largely unknown due
to the listing of Giardia as non-notifiable. Our results demonstrate
that screening by both microscopy and 18S rRNA PCR is
beneficial to accurately determine Giardia prevalence, the
presence of established infections, and to identify demographic
groups within the community that are most at risk from giardiasis.
DNA sequencing analyses of the 18S rRNA gene showed that
all Giardia cases in this remote community were caused by
assemblages A or B. Giardia duodenalis assemblage B was most
commonly identified overall (75%), at all time points, in all age
groups, and in both genders. The predominance of assemblage B
concords with other studies from Australia [17,26]. Further
genotyping at the gdh locus showed that a diversity of genetic
subtypes were present. Within assemblage A, only subassemblage
AII was identified. Subassemblage AII is most commonly
identified in humans [26] and anthroponotic transmission is likely.
Subassemblage AI, the most common human subassemblage
found in other animals [13,26] was not identified in this study.
Our results demonstrated that two assemblage B genotypes,
consistent with previous gdh BIII/BIV descriptions were detected
in this community, and both genotypes were detected separately,
and as mixed samples. Although designation of isolates to
subassemblages BIII or BIV is problematic, an accurate system
to classify assemblage B isolates that enables comparison between
studies is currently not available. All four types of Giardia
(subassemblage AII, BIII, BIV, and mixed samples of BIII/BIV)
were identified and persisted in the community over a 12 month
period.
Detection of mixed genetic variants in 28% of cases is high
when compared to data from low prevalence regions of Australia.
Studies of sporadic giardiasis in Western Australia and New South
Wales have detected mixed assemblage B samples in less than 6%
of samples screened [24,26]. The larger proportion of mixed
samples detected in this study may be indicative of environmental
contamination and high frequency transmission of different G.
duodenalis subtypes, and frequent host contact due to overcrowd-
ed living conditions, which may contribute to the higher
prevalence of mixed infections. The presence of mixed samples
can also be explained by nucleotide sequence heterogeneity among
assemblage B isolates [11,32]. The mechanisms that produce
sequence heterogeneity are unresolved, but genetic diversity may
be more prevalent in highly endemic environments due to
increased competition and selective pressures [6].
The results of this study have demonstrated high detection rates
of Giardia in children living in a remote Indigenous community in
the Northern Territory. Gastrointestinal infections remain a
significant cause of morbidity in remote Indigenous communities
and the burden of infectious diseases extends beyond childhood
[3]. The high proportion of positive cases detected in this study
among children confirms previous reports from remote Indigenous
communities. These results highlight the need for further research
to understand the contribution of giardiasis to chronic gastroin-
Giardia Subtypes in a Remote Indigenous Community
PLOS ONE | www.plosone.org 6 November 2014 | Volume 9 | Issue 11 | e112058
testinal disease, and to examine links between PCR positive cases
and clinical outcomes.
Giardia duodenalis assemblage B dominates transmission in this
community. A variety of G. duodenalis subtypes persist, and
reinfection of children with different genetic variants is possible.
The similar frequencies of assemblage A and B in this study to
other Australian communities warrants further investigation to
assess whether disease dynamics are similar between communities,
despite differences in prevalence. In contrast, conditions specific to
remote Indigenous communities may enhance mixed or hetero-
geneous infections.
Knowledge of parasite prevalence, infectious subtypes, and
community dynamics that enhance transmission are required to
address the continuing burden that gastrointestinal diseases impose
on children in remote Indigenous communities.
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